Bee Venom Alleviates Motor Deficits and Modulates the Transfer of Cortical Information through the Basal Ganglia in Rat Models of Parkinson's Disease
Nicolas Maurice, Thierry Deltheil, Christophe Melon, Bertrand Degos, Christiane Mourre, Marianne Amalric, Lydia Kerkerian-Le Goff, Nicolas Maurice, Thierry Deltheil, Christophe Melon, Bertrand Degos, Christiane Mourre, Marianne Amalric, Lydia Kerkerian-Le Goff
Abstract
Recent evidence points to a neuroprotective action of bee venom on nigral dopamine neurons in animal models of Parkinson's disease (PD). Here we examined whether bee venom also displays a symptomatic action by acting on the pathological functioning of the basal ganglia in rat PD models. Bee venom effects were assessed by combining motor behavior analyses and in vivo electrophysiological recordings in the substantia nigra pars reticulata (SNr, basal ganglia output structure) in pharmacological (neuroleptic treatment) and lesional (unilateral intranigral 6-hydroxydopamine injection) PD models. In the hemi-parkinsonian 6-hydroxydopamine lesion model, subchronic bee venom treatment significantly alleviates contralateral forelimb akinesia and apomorphine-induced rotations. Moreover, a single injection of bee venom reverses haloperidol-induced catalepsy, a pharmacological model reminiscent of parkinsonian akinetic deficit. This effect is mimicked by apamin, a blocker of small conductance Ca2+-activated K+ (SK) channels, and blocked by CyPPA, a positive modulator of these channels, suggesting the involvement of SK channels in the bee venom antiparkinsonian action. In vivo electrophysiological recordings in the substantia nigra pars reticulata (basal ganglia output structure) showed no significant effect of BV on the mean neuronal discharge frequency or pathological bursting activity. In contrast, analyses of the neuronal responses evoked by motor cortex stimulation show that bee venom reverses the 6-OHDA- and neuroleptic-induced biases in the influence exerted by the direct inhibitory and indirect excitatory striatonigral circuits. These data provide the first evidence for a beneficial action of bee venom on the pathological functioning of the cortico-basal ganglia circuits underlying motor PD symptoms with potential relevance to the symptomatic treatment of this disease.
Trial registration: ClinicalTrials.gov NCT01341431.
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
Figures
References
- Wichmann T, DeLong MR, Guridi J, Obeso JA. Milestones in research on the pathophysiology of Parkinson’s disease. Mov Disord. 2011;26: 1032–41. 10.1002/mds.23695
- Albin RL, Young AB, Penney JB. The functional anatomy of disorders of the basal ganglia. Trends Neurosci. 1995;18: 63–4.
- Pollak P, Fraix V, Krack P, Moro E, Mendes A, Chabardes S, et al. Treatment results: Parkinson’s disease. Mov Disord. 2002;17 Suppl 3: S75–83.
- Rascol O, Lozano A, Stern M, Poewe W. Milestones in Parkinson’s disease therapeutics. Mov Disord. 2011;26: 1072–82. 10.1002/mds.23714
- Lindvall O, Björklund A. Cell therapeutics in Parkinson’s disease. Neurotherapeutics. 2011;8: 539–48. 10.1007/s13311-011-0069-6
- Hickey P, Stacy M. Available and emerging treatments for Parkinson’s disease: a review. Drug Des Devel Ther. 2011;5: 241–54. 10.2147/DDDT.S11836
- Schapira AH. Progress in neuroprotection in Parkinson’s disease. Eur J Neurol. 2008;15 Suppl 1: 5–13. 10.1111/j.1468-1331.2008.02055.x
- Harris H, Rubinsztein DC. Control of autophagy as a therapy for neurodegenerative disease. Nat Rev Neurol. 2012;8: 108–17. 10.1038/nrneurol.2011.200
- Salthun-Lassalle B, Hirsch EC, Wolfart J, Ruberg M, Michel PP. Rescue of mesencephalic dopaminergic neurons in culture by low-level stimulation of voltage-gated sodium channels. J Neurosci. 2004;24: 5922–30. 10.1523/JNEUROSCI.5668-03.2004
- Doo AR, Kim ST, Kim SN, Moon W, Yin CS, Chae Y, et al. Neuroprotective effects of bee venom pharmaceutical acupuncture in acute 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced mouse model of Parkinson’s disease. Neurol Res. 2010;32 Suppl 1: 88–91. 10.1179/016164109X12537002794282
- Doo AR, Kim SN, Kim ST, Park JY, Chung SH, Choe BY, et al. Bee venom protects SH-SY5Y human neuroblastoma cells from 1-methyl-4-phenylpyridinium-induced apoptotic cell death. Brain Res. 2012;1429: 106–15. 10.1016/j.brainres.2011.10.003
- Kim JI, Yang EJ, Lee MS, Kim YS, Huh Y, Cho IH, et al. Bee venom reduces neuroinflammation in the MPTP-induced model of Parkinson’s disease. Int J Neurosci. 2011;121: 209–17. 10.3109/00207454.2010.548613
- Alvarez-Fischer D, Noelker C, Vulinović F, Grünewald A, Chevarin C, Klein C, et al. Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model. PLoS One. 2013;8: 2–9. 10.1371/journal.pone.0061700
- Khalil WKB, Assaf N, ElShebiney SA, Salem NA. Neuroprotective effects of bee venom acupuncture therapy against rotenone-induced oxidative stress and apoptosis. Neurochem Int. Elsevier Ltd; 2015;80: 79–86. 10.1016/j.neuint.2014.11.008
- Yang EJ, Jiang JH, Lee SM, Yang SC, Hwang HS, Lee MS, et al. Bee venom attenuates neuroinflammatory events and extends survival in amyotrophic lateral sclerosis models. J Neuroinflammation. BioMed Central Ltd; 2010;7: 69 10.1186/1742-2094-7-69
- Aumann TD, Gantois I, Egan K, Vais A, Tomas D, Drago J, et al. SK channel function regulates the dopamine phenotype of neurons in the substantia nigra pars compacta. Exp Neurol. 2008;213: 419–30. 10.1016/j.expneurol.2008.07.005
- Benítez BA, Belálcazar HM, Anastasía A, Mamah DT, Zorumski CF, Mascó DH, et al. Functional reduction of SK3-mediated currents precedes AMPA-receptor-mediated excitotoxicity in dopaminergic neurons. Neuropharmacology. Elsevier Ltd; 2011;60: 1176–86. 10.1016/j.neuropharm.2010.10.024
- Wulff H, Kolski-Andreaco A, Sankaranarayanan A, Sabatier J-M, Shakkottai V. Modulators of small- and intermediate-conductance calcium-activated potassium channels and their therapeutic indications. Curr Med Chem. 2007;14: 1437–57.
- Wang G, Zeng J, Ren R, Chen S. Potassium channels in the basal ganglia: promising new targets for the treatment of Parkinson’s disease. Front Biosci. 2008;13: 3825–38.
- Faber ESL. Functions and modulation of neuronal SK channels. Cell Biochem Biophys. 2009;55: 127–39. 10.1007/s12013-009-9062-7
- Chen L, Deltheil T, Turle-Lorenzo N, Liberge M, Rosier C, Watabe I, et al. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats. Int J Neuropsychopharmacol. 2014;17: 1295–306. 10.1017/S1461145714000236
- De Groot J. The rat forebrain in stereotaxic coordinates 1st ed Verhandelingen Der Konjnklijke Nederlanse Akademie Van Wetenschappen AN, editor. Amsterdam: N. V. Noord-Hollansche Uitgevers Maatschappij; 1959.
- Salin P, Manrique C, Forni C, Kerkerian-Le Goff L. High-Frequency Stimulation of the Subthalamic Nucleus Selectively Reverses Dopamine Denervation-Induced Cellular Defects in the Output Structures of the Basal Ganglia in the Rat. J Neurosci. 2002;22: 5137–5148.
- Schallert T, Fleming SM, Leasure JL, Tillerson JL, Bland ST. CNS plasticity and assessment of forelimb sensorimotor outcome in unilateral rat models of stroke, cortical ablation, parkinsonism and spinal cord injury. Neuropharmacology. 2000;39: 777–87.
- Paxinos G, Watson C. The rat brain in stereotaxic coordinates. 4th ed San Diego: Academic Press; 1998.
- Deniau JM, Menetrey A, Charpier S. The lamellar organization of the rat substantia nigra pars reticulata: segregated patterns of striatal afferents and relationship to the topography of corticostriatal projections. Neuroscience. 1996;73: 761–781.
- Maurice N, Deniau JM, Glowinski J, Thierry AM. Relationships between the Prefrontal Cortex and the Basal Ganglia in the Rat: Physiology of the Cortico-Nigral Circuits. J Neurosci. 1999;19: 4674–4681.
- Deniau JM, Hammond C, Riszk A, Féger J. Electrophysiological properties of identified output neurons of the rat substantia nigra (pars compacta and pars reticulata): evidences for the existence of branched neurons. Exp brain Res. 1978;32: 409–22.
- Bunney BS, Walters JR, Roth RH, Aghajanian GK. Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J Pharmacol Exp Ther. 1973;185: 560–71.
- Robin K, Maurice N, Degos B, Deniau JM, Martinerie J, Pezard L. Assessment of bursting activity and interspike intervals variability: a case study for methodological comparison. J Neurosci Methods. 2009;179: 142–9. 10.1016/j.jneumeth.2009.01.020
- Legéndy CR, Salcman M. Bursts and recurrences of bursts in the spike trains of spontaneously active striate cortex neurons. J Neurophysiol. 1985;53: 926–39.
- Kolomiets BP, Deniau JM, Glowinski J, Thierry AM. Basal ganglia and processing of cortical information: functional interactions between trans-striatal and trans-subthalamic circuits in the substantia nigra pars reticulata. Neuroscience. 2003;117: 931–938. 10.1016/S0306-4522(02)00824-2
- Beyeler A, Kadiri N, Navailles S, Boujema M Ben, Gonon F, Moine C Le, et al. Stimulation of serotonin2C receptors elicits abnormal oral movements by acting on pathways other than the sensorimotor one in the rat basal ganglia. Neuroscience. 2010;169: 158–70. 10.1016/j.neuroscience.2010.04.061
- Degos B, Deniau JM, Thierry AM, Glowinski J, Pezard L, Maurice N. Neuroleptic-induced catalepsy: electrophysiological mechanisms of functional recovery induced by high-frequency stimulation of the subthalamic nucleus. J Neurosci. 2005;25: 7687–7696.
- Inoue K, Koketsu D, Kato S, Kobayashi K, Nambu A, Takada M. Immunotoxin-mediated tract targeting in the primate brain: selective elimination of the cortico-subthalamic “hyperdirect” pathway. PLoS One. 2012;7: e39149 10.1371/journal.pone.0039149
- Nishibayashi H, Ogura M, Kakishita K, Tanaka S, Tachibana Y, Nambu A, et al. Cortically evoked responses of human pallidal neurons recorded during stereotactic neurosurgery. Mov Disord. 2011;26: 469–76. 10.1002/mds.23502
- Gerlach M, Riederer P. Animal models of Parkinson’s disease: an empirical comparison with the phenomenology of the disease in man. J Neural Transm. 1996;103: 987–1041.
- Stansfeld CE, Marsh SJ, Parcej DN, Dolly JO, Brown DA. Mast cell degranulating peptide and dendrotoxin selectively inhibit a fast-activating potassium current and bind to common neuronal proteins. Neuroscience. 1987;23: 893–902.
- Yang EJ, Kim SH, Yang SC, Lee SM, Choi S-M. Melittin restores proteasome function in an animal model of ALS. J Neuroinflammation. 2011;8: 69 10.1186/1742-2094-8-69
- Habermann E. Bee and Wasp Venoms. Science. 1972;177: 314–322. 10.1126/science.177.4046.314
- Kokot ZJ, Matysiak J. Simultaneous Determination of Major Constituents of Honeybee Venom by LC-DAD. Chromatographia. 2009;69: 1401–1405. 10.1365/s10337-009-1052-9
- Herrik KF, Redrobe JP, Holst D, Hougaard C, Sandager-Nielsen K, Nielsen AN, et al. CyPPA, a Positive SK3/SK2 Modulator, Reduces Activity of Dopaminergic Neurons, Inhibits Dopamine Release, and Counteracts Hyperdopaminergic Behaviors Induced by Methylphenidate. Front Pharmacol. 2012;3: 11 10.3389/fphar.2012.00011
- Steketee JD, Kalivas PW. Effect of microinjections of apamin into the A10 dopamine region of rats: a behavioral and neurochemical analysis. J Pharmacol Exp Ther. 1990;254: 711–9.
- Stocker M, Pedarzani P. Differential distribution of three Ca(2+)-activated K(+) channel subunits, SK1, SK2, and SK3, in the adult rat central nervous system. Mol Cell Neurosci. 2000;15: 476–93. 10.1006/mcne.2000.0842
- Sailer CA, Kaufmann WA, Marksteiner J, Knaus HG. Comparative immunohistochemical distribution of three small-conductance Ca2+-activated potassium channel subunits, SK1, SK2, and SK3 in mouse brain. Mol Cell Neurosci. 2004;26: 458–69. 10.1016/j.mcn.2004.03.002
- Sarpal D, Koenig JI, Adelman JP, Brady D, Prendeville LC, Shepard PD. Regional distribution of SK3 mRNA-containing neurons in the adult and adolescent rat ventral midbrain and their relationship to dopamine-containing cells. Synapse. 2004;53: 104–13. 10.1002/syn.20042
- Maltête D, Jodoin N, Karachi C, Houeto JL, Navarro S, Cornu P, et al. Subthalamic stimulation and neuronal activity in the substantia nigra in Parkinson’s disease. J Neurophysiol. 2007;97: 4017–22. 10.1152/jn.01104.2006
- Wichmann T, Bergman H, Starr PA, Subramanian T, Watts RL, DeLong MR. Comparison of MPTP-induced changes in spontaneous neuronal discharge in the internal pallidal segment and in the substantia nigra pars reticulata in primates. Exp brain Res. 1999;125: 397–409.
- Boraud T, Bezard E, Bioulac B, Gross CE. From single extracellular unit recording in experimental and human Parkinsonism to the development of a functional concept of the role played by the basal ganglia in motor control. Prog Neurobiol. 2002;66: 265–283. 10.1016/S0301-0082(01)00033-8
- Tai CH, Boraud T, Bezard E, Bioulac B, Gross C, Benazzouz A. Electrophysiological and metabolic evidence that high-frequency stimulation of the subthalamic nucleus bridles neuronal activity in the subthalamic nucleus and the substantia nigra reticulata. FASEB J. 2003;17: 1820–30. 10.1096/fj.03-0163com
- Sano H, Yasoshima Y, Matsushita N, Kaneko T, Kohno K, Pastan I, et al. Conditional ablation of striatal neuronal types containing dopamine D2 receptor disturbs coordination of basal ganglia function. J Neurosci. 2003;23: 9078–9088.
- Tachibana Y, Kita H, Chiken S, Takada M, Nambu A. Motor cortical control of internal pallidal activity through glutamatergic and GABAergic inputs in awake monkeys. Eur J Neurosci. 2008;27: 238–53. 10.1111/j.1460-9568.2007.05990.x
- Missale C, Nash SR, Robinson SW, Jaber M, Caron MG. Dopamine Receptors: From Structure to Function. Physiol Rev. 1998;78: 189–225.
- Angulo JA. Involvement of dopamine D1 and D2 receptors in the regulation of proenkephalin mRNA abundance in the striatum and accumbens of the rat brain. J Neurochem. 1992;58: 1104–9.
- Konieczny J, Wardas J, Kuter K, Pilc A, Ossowska K. The influence of group III metabotropic glutamate receptor stimulation by (1S,3R,4S)-1-aminocyclo-pentane-1,3,4-tricarboxylic acid on the parkinsonian-like akinesia and striatal proenkephalin and prodynorphin mRNA expression in rats. Neuroscience. 2007;145: 611–20. 10.1016/j.neuroscience.2006.12.006
- Drew KL, WT O’Connor, Kehr J, Ungerstedt U. Regional specific effects of clozapine and haloperidol on GABA and dopamine release in rat basal ganglia. Eur J Pharmacol. 1990;187: 385–97.
- Chapman MA, See RE. Differential effects of unique profile antipsychotic drugs on extracellular amino acids in the ventral pallidum and globus pallidus of rats. J Pharmacol Exp Ther. 1996;277: 1586–94.
- Arias-García MA, Tapia D, Flores-Barrera E, Pérez-Ortega JE, Bargas J, Galarraga E. Duration differences of corticostriatal responses in striatal projection neurons depend on calcium activated potassium currents. Front Syst Neurosci. Frontiers Media SA; 2013;7: 63 10.3389/fnsys.2013.00063
Source: PubMed